SE7411806L - - Google Patents

Info

Publication number
SE7411806L
SE7411806L SE7411806A SE7411806A SE7411806L SE 7411806 L SE7411806 L SE 7411806L SE 7411806 A SE7411806 A SE 7411806A SE 7411806 A SE7411806 A SE 7411806A SE 7411806 L SE7411806 L SE 7411806L
Authority
SE
Sweden
Application number
SE7411806A
Other versions
SE410600B (sv
Inventor
C Fauran
G Bourgery
G Raynaud
C Gouret
Original Assignee
Delalande Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7333831A external-priority patent/FR2244459A1/fr
Priority claimed from FR7410327A external-priority patent/FR2265386A2/fr
Application filed by Delalande Sa filed Critical Delalande Sa
Publication of SE7411806L publication Critical patent/SE7411806L/xx
Publication of SE410600B publication Critical patent/SE410600B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE7411806A 1973-09-20 1974-09-19 Sett att framstella nya arylaminopyrimidinderivat SE410600B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7333831A FR2244459A1 (en) 1973-09-20 1973-09-20 2-Arylamino-pyrimidines - useful as sedatives, antiinflammatory, anti-ulcer, vasodilating, anticholinergic and anti-broncho- constricting agents and diuretics
FR7410327A FR2265386A2 (en) 1974-03-26 1974-03-26 2-Arylamino-pyrimidines - useful as sedatives, antiinflammatory, anti-ulcer, vasodilating, anticholinergic and anti-broncho- constricting agents and diuretics

Publications (2)

Publication Number Publication Date
SE7411806L true SE7411806L (zh) 1975-03-21
SE410600B SE410600B (sv) 1979-10-22

Family

ID=26217948

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7411806A SE410600B (sv) 1973-09-20 1974-09-19 Sett att framstella nya arylaminopyrimidinderivat

Country Status (12)

Country Link
US (1) US3978055A (zh)
JP (1) JPS5088079A (zh)
CA (1) CA1008074A (zh)
CH (1) CH593266A5 (zh)
DE (1) DE2444426A1 (zh)
ES (1) ES429869A1 (zh)
GB (1) GB1430729A (zh)
IT (1) IT1062796B (zh)
LU (1) LU70791A1 (zh)
NL (1) NL7412494A (zh)
SE (1) SE410600B (zh)
SU (1) SU645569A3 (zh)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1534593A (en) * 1976-09-03 1978-12-06 Soc D Etudes Prod Chimique N-2,6-dichlorophenyl-2-aminopyrimidine and therapeutic compositions containing it
JPS57203072A (en) * 1981-06-05 1982-12-13 Sankyo Co Ltd 4-anilinopyrimidine derivative, its preparation, antidepressant comprising it as active ingredient
US4466965A (en) * 1982-07-26 1984-08-21 American Hospital Supply Corporation Phthalazine compounds, compositions and use
US5254555A (en) * 1989-10-30 1993-10-19 Beecham Group P.L.C. Amino pyrimidin-7-yl substituted benzopyrans for treatment of hypertension
US7481790B2 (en) * 2000-12-27 2009-01-27 Advanced Cardiovascular Systems, Inc. Vessel enlargement by arteriogenic factor delivery
DE10133665A1 (de) * 2001-07-11 2003-01-30 Boehringer Ingelheim Pharma Carbonsäurederivate, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Herstellung
US20030055263A1 (en) * 2001-07-11 2003-03-20 Boehringer Ingelheim Pharma Kg Carboxylic acid derivatives, medicaments comprising these compounds, their use and processes for their production
US7320989B2 (en) * 2003-02-28 2008-01-22 Encysive Pharmaceuticals, Inc. Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists
WO2004078114A2 (en) * 2003-02-28 2004-09-16 Encysive Pharmaceuticals Inc. Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-ii receptor antagonists.
WO2005047268A2 (en) * 2003-11-10 2005-05-26 X-Ceptor Therapeutics, Inc. Substituted pyrimidine compositions and methods of use
US7981900B2 (en) * 2003-12-03 2011-07-19 Ym Biosciences Australia Pty Ltd 2-phenyl pyrimidines which are tubulin inhibitors
EA035349B1 (ru) 2012-11-21 2020-05-29 ПиТиСи ТЕРАПЬЮТИКС, ИНК. ЗАМЕЩЕННЫЕ ПИРИМИДИНОВЫЕ ОБРАТНЫЕ ИНГИБИТОРЫ Bmi-1
AU2013399092A1 (en) 2013-08-30 2016-03-17 Ptc Therapeutics, Inc. Substituted pyrimidine Bmi-1 inhibitors
WO2015076800A1 (en) 2013-11-21 2015-05-28 Ptc Therapeutics, Inc. Substituted pyridine and pyrazine bmi-1 inhibitors
CN104262263B (zh) * 2014-08-29 2017-01-11 西安交通大学 一种N,6二苯基嘧啶-4-胺类Bcr-Abl抑制剂及其制备方法和应用
AU2019340402A1 (en) 2018-08-17 2021-03-25 Ptc Therapeutics, Inc. Method for treating pancreatic cancer
CN113710670A (zh) * 2019-02-28 2021-11-26 Ptc医疗公司 治疗多发性骨髓瘤的方法
MX2021011688A (es) * 2019-03-27 2022-01-24 Ptc Therapeutics Inc Combinaciones utiles en un metodo para tratar sarcoma.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3321478A (en) * 1963-09-20 1967-05-23 American Cyanamid Co Aminoethoxyphenyl amine, ether, and sulfide derivatives of pyrimidine

Also Published As

Publication number Publication date
SE410600B (sv) 1979-10-22
ES429869A1 (es) 1976-10-01
DE2444426A1 (de) 1975-03-27
AU7344174A (en) 1976-03-25
CH593266A5 (zh) 1977-11-30
US3978055A (en) 1976-08-31
LU70791A1 (zh) 1975-06-11
IT1062796B (it) 1985-01-31
NL7412494A (nl) 1975-03-24
JPS5088079A (zh) 1975-07-15
SU645569A3 (ru) 1979-01-30
GB1430729A (en) 1976-04-07
CA1008074A (fr) 1977-04-05

Similar Documents

Publication Publication Date Title
AR201758A1 (zh)
AU476761B2 (zh)
AU465372B2 (zh)
AR201235Q (zh)
AR201231Q (zh)
AU474593B2 (zh)
AU474511B2 (zh)
AU474838B2 (zh)
JPS5088079A (zh)
AU471343B2 (zh)
AU465453B2 (zh)
AU465434B2 (zh)
AU450229B2 (zh)
AU476714B2 (zh)
AR201229Q (zh)
AU466283B2 (zh)
AU476696B2 (zh)
AU472848B2 (zh)
AR199451A1 (zh)
AU477823B2 (zh)
AR200885A1 (zh)
AR195311A1 (zh)
AR200256A1 (zh)
AR201432A1 (zh)
AU477824B2 (zh)